Výsledky vyhledávání - "Phan Vu Thuy Dung"

Akademický článek

WNT1-inducible signaling pathway protein 1 activation through C-X-C motif chemokine ligand 5/C-X-C chemokine receptor type 2/leukemia inhibitory factor/leukemia inhibitory factor receptor signaling promotes immunosuppression and neuroendocrine differentiation in prostate cancer

Autor: Ke Hung Tsui, Chien-Liang Liu, Hsiu-Lien Yeh, Ming-Kun Liu, Chien-Hsiu Li, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Phan Vu Thuy Dung, Michael Hsiao, Wassim Abou-Kheir, Yen-Nien Liu

Publikováno v: iScience, Vol 27, Iss 8, Pp 110562- (2024)

Summary: The interaction between prostate cancer (PCa) cells and prostate stromal cells fosters an immunosuppressive tumor microenvironment (TME) that promotes tumor growth and immune evasion. However, the specific signaling pathways involved remain

Externí odkaz: https://doaj.org/article/b2660cab58d940baabbe7a276815442f

Zobrazit plný text záznamu

Akademický článek

CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer

Autor: Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu

Publikováno v: Cell Death and Disease, Vol 14, Iss 5, Pp 1-15 (2023)

Abstract Current treatment options for prostate cancer focus on targeting androgen receptor (AR) signaling. Inhibiting effects of AR may activate neuroendocrine differentiation and lineage plasticity pathways, thereby promoting the development of neu

Externí odkaz: https://doaj.org/article/592d69a507654d59b898cc32c81f3e2b

Zobrazit plný text záznamu

Akademický článek

Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer

Autor: Wei-Yu Chen, Phan Vu Thuy Dung, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Zi-Qing Chen, Michael Hsiao, Jiaoti Huang, Yu-Ching Wen, Yen-Nien Liu

Publikováno v: Redox Biology, Vol 62, Iss , Pp 102686- (2023)

Conventional treatment of prostate cancer (PCa) uses androgen-deprivation therapy (ADT) to inhibit androgen receptor (AR) signaling-driven tumor progression. ADT-induced PCa recurrence may progress to an AR-negative phenotype with neuroendocrine (NE)

Externí odkaz: https://doaj.org/article/ce24179a46364bfaa956e050217da070

Zobrazit plný text záznamu

Akademický článek

Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer

Autor: Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, Han-Ru Li, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen, Yen-Nien Liu

Publikováno v: Cell Death and Disease, Vol 15, Iss 1, Pp 1-1 (2024)

Externí odkaz: https://doaj.org/article/02ec34929e6d45c8a7f5c70ba48e6eeb

Zobrazit plný text záznamu

Akademický článek

Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features

Autor: Van Thi Ngoc Tram, Hoang Dang Khoa Ta, Gangga Anuraga, Phan Vu Thuy Dung, Do Thi Minh Xuan, Sanskriti Dey, Chih-Yang Wang, Yen-Nien Liu

Publikováno v: International Journal of Molecular Sciences, Vol 24, Iss 15, p 11930 (2023)

Prostate cancer (PCa) is one of the most prevalent cancers in men, yet its pathogenic pathways remain poorly understood. Transcriptomics and high-throughput sequencing can help uncover cancer diagnostic targets and understand biological circuits. Usi

Externí odkaz: https://doaj.org/article/e21a3fc091084d87b916d83ef48ffc30

Zobrazit plný text záznamu

MCTP1 promotes SNAI1-driven neuroendocrine differentiation and epithelial-to- mesenchymal transition of prostate cancer enhancement by ZBTB46/FOXA2/HIF1A

Autor: Yen-Nien Liu, Wei-Yu Chen, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Van Thi Ngoc Tram, Phan Vu Thuy Dung, Zi-Qing Chen, Michael Hsiao, Jiaoti Huang, Yu-Ching Wen

Background Prostate cancer (PCa) patients with bone metastases frequently exhibit abnormal calcium homeostasis. However, the molecular mechanisms underlying bone metastasis mediated by activated calcium transport signaling remain unclear. Our results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6c7c1cab75486baceb3aff4faf114035
https://doi.org/10.21203/rs.3.rs-1709799/v1

Zobrazit plný text záznamu

Abstract 3062: ROMO1 mediates mitochondrial function links to neuroendocrine differentiation of prostate cancer enhancement by the nuclear PKLR/MYCN/MAX complex

Autor: Yen-Nien Liu, Wei-Yu Chen, Phan Vu Thuy Dung, Hsiu-Lien Yeh, Zi-Qing Chen, Wan-Hsin Wang, Yu-Ching Wen

Publikováno v: Cancer Research. 83:3062-3062

Conventional treatment of prostate cancer (PCa) uses androgen deprivation therapy (ADT) to inhibit androgen receptor (AR) signaling-driven tumor progression. ADT-induced PCa recurrence may progress to AR-negative phenotype with neuroendocrine (NE) fe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ac1114f4457dd229468e667239bf2ed
https://doi.org/10.1158/1538-7445.am2023-3062

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání